Moxifloxacin (MX) is an 8-methoxyquinolone antimicrobial drug, which is often used as a positive control in thorough QT (TQT) studies. In the present study we established the population ...
February 19, 2009 (Portland, Oregon) — Both diabetes and QT-interval-prolonging medications were significant and independent risk factors for sudden cardiac death (SCD) among members of a ...
(HealthDay News) — Use of a computerized clinical decision support system (CDSS) may reduce the risk of prolonged QT c interval in hospitalized patients at risk for torsades de pointes, according to ...
There were 252 patients with EKG results included for the analysis; they were given concomitant therapy for median 7 days. This article is written live from ID Week 2017 Annual Meeting in San Diego, ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 infection is associated with a significant increase in the corrected QT interval (QTc) in ...
MONTREAL, Aug. 25, 2023 /PRNewswire/ - Thryv Therapeutics Inc. today announced positive results of the WAVE 1 Proof of Concept clinical study evaluating LQT-1213 for the reduction of QTcF in ...
Please provide your email address to receive an email when new articles are posted on . Treatment with hydroxychloroquine does not impact corrected QT length among patients with rheumatoid arthritis ...
Results to be Included in BYDUREON™ New Drug Application Resubmission in the Third Quarter of 2011 SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)-- Amylin Pharmaceuticals, Inc. (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback